Current Cardiology Reports

, 21:107 | Cite as

Clinical Utility of [18F]FDG-PET /CT in Pericardial Disease

  • Min-Sun Kim
  • Eun-Kyung Kim
  • Joon Young Choi
  • Jae K. Oh
  • Sung-A ChangEmail author
Pericardial Disease (AL Klein and CL Jellis, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Pericardial Disease


Identification of the etiology of pericardial disease is challenging because the accessibility to pericardial fluid and tissue is limited and there is a relatively low yield of fluid and tissue analysis. Pericardial disease is associated with various systemic diseases and is frequently a first manifestation of other systemic diseases. Detecting the cause of pericarditis and minimizing the subsequent inflammatory process can possibly prevent long-term complications.

Purpose of Review

To review the clinical utility of [18F]-2-deoxy-2-fluoro-D-glucose positron emission tomography/computed tomography ([18F]FDG-PET/CT) in the diagnosis and treatment of pericardial disease.

Recent Findings

[18F]FDG-PET/CT can visualize the hypermetabolic tissues of both malignancy and inflammation. Distribution of [18F]FDG-PET/CT uptake can provide information for neoplastic disease. If malignancy is ruled out, high uptake of pericardium is associated with active inflammation of the pericardium, and thus response to anti-inflammatory agents can also be predicted with [18F]FDG-PET/CT imaging.


[18F]FDG-PET/CT can be helpful for diagnosing and establishing prognosis and for planning for anti-inflammatory treatment in pericardial disease.


Positron emission tomography Pericardial disease Pericarditis Constrictive pericarditis 


Compliance with Ethical Standards

Conflict of Interest

Min-Sun Kim, Eun-Kyung Kim, Joon Young Choi, Jae K. Oh, and Sung-A Chang declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).


Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. 1.
    Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921–64.CrossRefGoogle Scholar
  2. 2.
    Vaidyanathan S, Patel CN, Scarsbrook AF, Chowdhury FU. FDG PET/CT in infection and inflammation--current and emerging clinical applications. Clin Radiol. 2015;70(7):787–800. Scholar
  3. 3.
    Restrepo CS, Vargas D, Ocazionez D, Martinez-Jimenez S, Betancourt Cuellar SL, Gutierrez FR. Primary pericardial tumors. Radiographics. 2013;33(6):1613–30. Scholar
  4. 4.
    Imazio M, Cecchi E, Demichelis B, Ierna S, Demarie D, Ghisio A, et al. Indicators of poor prognosis of acute pericarditis. Circulation. 2007;115(21):2739–44.CrossRefGoogle Scholar
  5. 5.
    Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y. Controversial issues in the management of pericardial diseases. Circulation. 2010;121(7):916–28.CrossRefGoogle Scholar
  6. 6.
    Sagristà-Sauleda J, Mercé J, Permanyer-Miralda G, Soler-Soler J. Clinical clues to the causes of large pericardial effusions. Am J Med. 2000;109(2):95–101.CrossRefGoogle Scholar
  7. 7.
    Søgaard KK, Farkas DK, Ehrenstein V, Bhaskaran K, Bøtker HE, Sørensen HT. Pericarditis as a marker of occult cancer and a prognostic factor for cancer mortality. Circulation. 2017;136(11):996–1006.CrossRefGoogle Scholar
  8. 8.
    Seferović PM, Ristić AD, Maksimović R, Tatić V, Ostojić M, Kanjuh V. Diagnostic value of pericardial biopsy: improvement with extensive sampling enabled by pericardioscopy. Circulation. 2003;107(7):978–83.CrossRefGoogle Scholar
  9. 9.
    Dragoescu EA, Liu L. Pericardial fluid cytology: an analysis of 128 specimens over a 6-year period. Cancer Cytopathol. 2013;121(5):242–51.CrossRefGoogle Scholar
  10. 10.
    Behnia FL, Leblond A. Vesselle H. A practical guide to interpreting FDG PET and CT nodal findings in lung cancer. J Nucl Med Rad Ther. 2016;8(1). doi:
  11. 11.
    Imazio M, Gaita F. Diagnosis and treatment of pericarditis. Heart. 2015;101(14):1159–68.CrossRefGoogle Scholar
  12. 12.
    Imazio M, Brucato A, Barbieri A, Ferroni F, Maestroni S, Ligabue G, et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation. 2013;128(1):42–9.CrossRefGoogle Scholar
  13. 13.
    Stensaeth KH, Hoffmann P, Fossum E, Mangschau A, Sandvik L, Klow NE. Cardiac magnetic resonance visualizes acute and chronic myocardial injuries in myocarditis. Int J Card Imaging. 2012;28(2):327–35.CrossRefGoogle Scholar
  14. 14.
    Nensa F, Kloth J, Tezgah E, Poeppel TD, Heusch P, Goebel J, et al. Feasibility of FDG-PET in myocarditis: comparison to CMR using integrated PET/MRI. J Nucl Cardiol. 2018;25(3):785–94.CrossRefGoogle Scholar
  15. 15.
    Van Riet J, Hill EE, Gheysens O, Dymarkowski S, Herregods M-C, Herijgers P, et al. 18 F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur J Nucl Med Mol Imaging. 2010;37(6):1189–97.CrossRefGoogle Scholar
  16. 16.
    Chang S-A. Tuberculous and infectious pericarditis. Cardiol Clin. 2017;35(4):615–22.CrossRefGoogle Scholar
  17. 17.
    Sagrista-Sauleda J, Permanyer-Miralda G, Soler-Soler J. Tuberculous pericarditis: ten year experience with a prospective protocol for diagnosis and treatment. J Am Coll Cardiol. 1988;11(4):724–8.CrossRefGoogle Scholar
  18. 18.
    Sathekge MM, Maes A, Pottel H, Stoltz A, van de Wiele C. Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area. S Afr Med J. 2010;100(9):598–601.CrossRefGoogle Scholar
  19. 19.
    Dong A, Dong H, Wang Y, Cheng C, Zuo C, Lu J. (18)F-FDG PET/CT in differentiating acute tuberculous from idiopathic pericarditis: preliminary study. Clin Nucl Med. 2013;38(4):e160–5. Scholar
  20. 20.
    Vorster M, Sathekge MM, Bomanji J. Advances in imaging of tuberculosis: the role of (1)(8)F-FDG PET and PET/CT. Curr Opin Pulm Med. 2014;20(3):287–93. Scholar
  21. 21.
    Mookadam F, Jiamsripong P, Raslan SF, Panse PM, Tajik AJ. Constrictive pericarditis and restrictive cardiomyopathy in the modern era. Futur Cardiol. 2011;7(4):471–83. Scholar
  22. 22.
    Bertog SC, Thambidorai SK, Parakh K, Schoenhagen P, Ozduran V, Houghtaling PL, et al. Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol. 2004;43(8):1445–52. Scholar
  23. 23.
    Oh JK, Hatle LK, Seward JB, Danielson GK, Schaff HV, Reeder GS, et al. Diagnostic role of Doppler echocardiography in constrictive pericarditis. J Am Coll Cardiol. 1994;23(1):154–62.CrossRefGoogle Scholar
  24. 24.
    Oh JY, Chang SA, Choe YH, Kim DK. Transient constrictive pericarditis in systemic lupus erythematous. Eur Heart J Cardiovasc Imaging. 2012;13(9):793. Scholar
  25. 25.
    Baker CM, Orsinelli DA. Subacute effusive-constrictive pericarditis: diagnosis by serial echocardiography. J Am Soc Echocardiogr. 2004;17(11):1204–6.CrossRefGoogle Scholar
  26. 26.
    Haley JH, Tajik AJ, Danielson GK, Schaff HV, Mulvagh SL, Oh JK. Transient constrictive pericarditis: causes and natural history. J Am Coll Cardiol. 2004;43(2):271–5.CrossRefGoogle Scholar
  27. 27.
    Sagrista-Sauleda J, Permanyer-Miralda G, Candell-Riera J, Angel J, Soler-Soler J. Transient cardiac constriction: an unrecognized pattern of evolution in effusive acute idiopathic pericarditis. Am J Cardiol. 1987;59(9):961–6.CrossRefGoogle Scholar
  28. 28.
    Feng D, Glockner J, Kim K, Martinez M, Syed IS, Araoz P, et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study. Circulation. 2011;124(17):1830–7. Scholar
  29. 29.
    •• Chang SA, Choi JY, Kim EK, Hyun SH, Jang SY, Choi JO, et al. [(18)F]Fluorodeoxyglucose PET/CT predicts response to steroid therapy in constrictive pericarditis. J Am Coll Cardiol. 2017;69(6):750–2. Finding from this study suggests the role of [ 18 F]FDG-PET/CT in visualization of reversible pericardial inflammation constributing to treatment of transient constrictive pericarditis.CrossRefPubMedGoogle Scholar
  30. 30.
    Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016;23(5):1187–226.CrossRefGoogle Scholar
  31. 31.
    Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T, Tsujino I, et al. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial 18 F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol. 2016;23(2):244–52.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Min-Sun Kim
    • 1
  • Eun-Kyung Kim
    • 1
  • Joon Young Choi
    • 2
  • Jae K. Oh
    • 3
  • Sung-A Chang
    • 1
    Email author
  1. 1.Division of Cardiology, Department of Medicine, Samsung Medical Center, Heart Vascular and Stroke Institute Imaging CenterSungkyunkwan University School of MedicineSeoulKorea
  2. 2.Department of Nuclear Medicine and Molecular Imaging, Samsung Medical CenterSungkyunkwan University School of MedicineSeoulKorea
  3. 3.Department of Cardiovascular MedicineMayo Clinic College of MedicineRochesterUSA

Personalised recommendations